PHILADELPHIA -- J. Larry Jameson, M.D., Ph.D., has been named the next executive vice president of the University of Pennsylvania for the Health System and dean of Penn’s School of Medicine, effective July 1, 2011.
The announcement was made today by Penn President Amy Gutmann.
Jameson will join Penn from Northwestern University, where he has served since 2007 as vice president for medical affairs and the Lewis Landsberg Dean of the Feinberg School of Medicine.
“Larry Jameson is an eminent researcher, educator and clinician with a sterling track record of inspired leadership, a deep appreciation for Penn Medicine’s exceptional faculty, students and clinical programs, an unwavering ethical compass, and a desire to broadly engage with the entire Penn community,” Gutmann said. “He is deeply committed to integrating research, education, and clinical practice through interdisciplinary collaborations and partnerships.”
Jameson will be responsible for the oversight and strategic management of all of Penn Medicine’s academic programs, research activities and clinical services. Ralph Muller, the CEO of the University of Pennsylvania Health System, will report to Jameson.
“Penn Medicine's close integration of clinical, research, and educational programs represents the future of academic medicine,” Jameson said. “I look forward to partnering with Penn's faculty, students, and staff to lead Penn Medicine’s clinical, educational and research programs to even greater heights of quality and prominence and influence the practice of medicine worldwide.”
“Larry Jameson is a strong leader who brings deep experience and proven success in leading high quality academic and clinical programs,” said Penn Provost Vincent Price, who chaired the consultative committee that advised Gutmann during the search. “I am excited to work with him to continue propelling forward the vision for Penn that President Gutmann has articulated in the Penn Compact.”
As vice president and dean at Northwestern, Jameson has focused on interdisciplinary research and clinical programs. Before becoming vice president and dean, he was the Irving S. Cutter Professor of Medicine and chair of the Department of Medicine at Northwestern for seven years, where he led initiatives that increased research funding and clinical activity, redesigned residency and physician-scientist training programs, and developed new faculty mentoring and leadership programs.
Jameson began his tenure at Northwestern in 1993 as chief of the Division of Endocrinology, Metabolism and Molecular Medicine. Earlier in his career, he was associate professor of medicine at the Harvard Medical School and chief of the Thyroid Unit at Massachusetts General Hospital.
An internationally recognized researcher, Jameson’s pioneering work in molecular endocrinology has greatly improved understanding of the transcription of endocrine genes and the genetic basis of reproductive and metabolic disorders. His work has helped bridge laboratory studies with clinical endocrinology, a vitally important experience as Penn Medicine prepares to open a new Translational Research Center adjacent to the Perelman Center for Advanced Medicine and Roberts Proton Therapy Center.
Jameson has authored more than 300 scientific articles and chapters, including studies that have been published in leading journals such as the New England Journal of Medicine, Nature Genetics, Science, and the Journal of Clinical Investigation.
Jameson is an editor of Harrison’s Principles of Internal Medicine, the most widely used textbook in the field worldwide. He is co-author of DeGroot and Jameson’s Endocrinology, the most comprehensive text in endocrinology, now in its sixth edition, and he is author of the award-winning Jameson’s Principles of Molecular Medicine, which serves as a principal text in this interdisciplinary field, fostering the bedside clinical application of basic scientific research.
Jameson was elected to the Institute of Medicine, the American Academy of Arts and Sciences, the American Society of Clinical Investigation and the Association of American Physicians. He has served as president of the Endocrine Society, as a member of the medical advisory board of the Howard Hughes Medical Institute, as a director of the American Board of Internal Medicine, and as a member of the Jury for the Lasker Award. He has also been the recipient of distinguished awards, including the Van Meter Award from the American Thyroid Association, Thomas G. Sheen Award from the American College of Surgeons, and Oppenheimer and Koch Awards from the Endocrine Society.
Jameson received his doctor of medicine degree with honors and a Ph.D. in biochemistry from the University of North Carolina in 1981. He received his clinical training in internal medicine at Massachusetts General Hospital.
Jameson will succeed Arthur Rubenstein, who has served as Executive Vice President and Dean at Penn since 2001.
Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $5.3 billion enterprise.
The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 18 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $373 million awarded in the 2015 fiscal year.
The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center -- which are recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report -- Chester County Hospital; Lancaster General Health; Penn Wissahickon Hospice; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Chestnut Hill Hospital and Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2015, Penn Medicine provided $253.3 million to benefit our community.